Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice

The outcome of patients with acute venous thromboembolism (VTE) and abnormal platelet count (PlC) at baseline has not been consistently studied. In real-world clinical practice, a number of patients with abnormal PlC receive vitamin K antagonists (VKAs) to treat acute VTE despite their higher risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Giorgi-Pierfranceschi, Matteo, Di Micco, Pierpaolo, Cattabiani, Chiara, Guida, Anna, Pagán, Barbara, Morales, Maria del Valle, Salgado, Estuardo, Suriñach, José Maria, Tolosa, Carles, Monreal, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058956/
https://www.ncbi.nlm.nih.gov/pubmed/26632687
http://dx.doi.org/10.1097/MD.0000000000001915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058956/
https://www.ncbi.nlm.nih.gov/pubmed/26632687
http://dx.doi.org/10.1097/MD.0000000000001915

Ejemplares similares